SAO · RDOR3.SA
Rede D'Or São Luiz S.A.
R$31.45-R$0.90 (-2.78%)
Rede D'Or São Luiz S.A.’s quoted price sits in the lower half of its reported 52-week range, 35.03% below the high.
Loading market information…
SAO · RADL3.SA · BRL
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:08 PM UTC. Cached market data; not a live quote.
One-year closing-price history · BRL. Historical prices are not a forecast.
Raia Drogasil S.A.’s quoted price sits in the lower half of its reported 52-week range, 44.86% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Raia Drogasil S.A.’s forward annual dividend is R$0.37 per share, paid quarterly. The forward yield is 2.42% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Raia Drogasil S.A.’s next earnings report is currently expected on Nov 3, 2026, with estimated earnings per share of R$0.26. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Raia Drogasil S.A.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.
Latest available per-share figures in BRL. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:24 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | May 6, 2025 | R$0.10-26.03% vs estimate | R$10.05B-4.27% vs estimate |
|---|
| Q4 2024 | Feb 25, 2025 | R$0.21+21.88% vs estimate | R$9.54B-6.36% vs estimate |
|---|
| Q3 2024 | Nov 5, 2024 | R$0.20+17.65% vs estimate | R$9.99B-1.96% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
R$31.45-R$0.90 (-2.78%)
Rede D'Or São Luiz S.A.’s quoted price sits in the lower half of its reported 52-week range, 35.03% below the high.
R$14.15-R$0.62 (-4.2%)
Bradsaude S.A.’s quoted price sits in the upper half of its reported 52-week range, 14.48% below the high.
R$21.37-R$0.15 (-0.7%)
Hypera S.A.’s quoted price sits in the lower half of its reported 52-week range, 28.77% below the high.
R$20.40-R$0.34 (-1.64%)
Fleury S.A.’s quoted price sits in the lower half of its reported 52-week range, 28.8% below the high.
R$3.01+R$0.06 (+2.03%)
Diagnósticos da América S.A.’s quoted price sits in the lower half of its reported 52-week range, 48.01% below the high.
R$9.15-R$0.20 (-2.14%)
Blau Farmacêutica S.A.’s quoted price sits in the lower half of its reported 52-week range, 36.9% below the high.
R$2.50-R$0.06 (-2.34%)
Empreendimentos Pague Menos S.A.’s quoted price sits in the lower half of its reported 52-week range, 67.19% below the high.
R$10.09-R$0.20 (-1.94%)
Dimed S.A. Distribuidora de Medicamentos’s quoted price sits in the lower half of its reported 52-week range, 38.99% below the high.
